Retinoblastoma is a prevalent type of eye cancer that is commonly found in children, with an average age of diagnosis at 18 months. It is caused by a loss of function of the retinoblastoma tumor suppressor gene on chromosome 13, which is inherited in an autosomal dominant pattern. About 10% of cases are hereditary. The most common presenting symptom is the absence of red-reflex, which is replaced by a white pupil (leukocoria). Other possible features include strabismus and visual problems.

When it comes to managing retinoblastoma, enucleation is not the only option. Depending on how advanced the tumor is, other treatment options include external beam radiation therapy, chemotherapy, and photocoagulation. The prognosis for retinoblastoma is excellent, with over 90% of patients surviving into adulthood.

Recurrent Chest Infections and Bronchiectasis: A Possible Sign of Cystic Fibrosis

Patients who have a history of recurrent chest infections and x-ray appearances that suggest bronchiectasis may be showing signs of cystic fibrosis. Bronchiectasis is a condition where the airways in the lungs become damaged and widened, leading to a build-up of mucous and bacteria. This can cause recurrent chest infections, which can be difficult to treat. Cystic fibrosis is a genetic condition that affects the production of mucous, leading to thick and sticky secretions that can block the airways and cause infections.

If a patient is showing signs of bronchiectasis, it is important to consider cystic fibrosis as a possible cause. Early diagnosis and treatment of cystic fibrosis can help to manage symptoms and prevent complications. Testing for cystic fibrosis may involve a sweat test, genetic testing, or other diagnostic tests. Treatment may include medications to help clear mucous from the airways, antibiotics to treat infections, and other therapies to manage symptoms.

The most common childhood cancer is ALL, which is characterized by anaemia, neutropaenia, and thrombocytopaenia. Symptoms include pallor, lethargy, splenomegaly, and petechiae. In contrast, aplastic anaemia is characterized by pancytopenia and hypoplastic bone marrow, which would result in leukopenia instead of leukocytosis. Thalassaemia, a genetic condition that causes anaemia, does not match the patient’s blood film or clinical presentation. ITP, an immune-mediated reduction in platelet count, would not explain the leukocytosis and neutropaenia seen in the patient. Meningitis, which can cause fever and purpura, is unlikely to be bacterial meningitis as it would result in neutrophilia instead of neutropaenia.

Acute lymphoblastic leukaemia (ALL) is a type of cancer that commonly affects children and accounts for 80% of childhood leukaemias. It is most prevalent in children between the ages of 2-5 years, with boys being slightly more affected than girls. Symptoms of ALL can be divided into those caused by bone marrow failure, such as anaemia, neutropaenia, and thrombocytopenia, and other features like bone pain, splenomegaly, and hepatomegaly. Fever is also present in up to 50% of new cases, which may indicate an infection or a constitutional symptom. Testicular swelling may also occur.

There are three types of ALL: common ALL, T-cell ALL, and B-cell ALL. Common ALL is the most common type, accounting for 75% of cases, and is characterized by the presence of CD10 and a pre-B phenotype. Poor prognostic factors for ALL include age less than 2 years or greater than 10 years, a white blood cell count greater than 20 * 109/l at diagnosis, T or B cell surface markers, non-Caucasian ethnicity, and male sex.

If a child under the age of 3 presents with an acute limp, it is crucial to arrange urgent assessment in secondary care. This is because they are at a higher risk of septic arthritis and child maltreatment, according to Nice Clinical Knowledge Summaries. Additionally, the diagnosis of transient synovitis should be made with extreme caution after ruling out serious causes of limp, as it is rare in this age group. Urgent referral for assessment is recommended due to the difficulty in examining and identifying subtle clinical signs.

Causes of Limping in Children

Limping in children can be caused by various factors, which may differ depending on the child’s age. One possible cause is transient synovitis, which has an acute onset and is often accompanied by viral infections. This condition is more common in boys aged 2-12 years. On the other hand, septic arthritis/osteomyelitis may cause a child to feel unwell and have a high fever. Juvenile idiopathic arthritis may cause a painless limp, while trauma can usually be diagnosed through the child’s history. Development dysplasia of the hip is usually detected in neonates and is six times more common in girls. Perthes disease, which is due to avascular necrosis of the femoral head, is more common in children aged 4-8 years. Finally, slipped upper femoral epiphysis may occur in children aged 10-15 years and is characterized by the displacement of the femoral head epiphysis postero-inferiorly. It is important to identify the cause of a child’s limp in order to provide appropriate treatment and prevent further complications.

To maintain a patent ductus arteriosus in cyanotic congenital heart diseases, prostaglandin E1 is recommended. This is particularly important in cases of transposition of the great arteries (TGA), where alprostadil is given to ensure some flow of oxygenated blood to the body. Neonatal apnoea is managed with caffeine, but it is not the primary medication used in TGA. Corticosteroids are administered to pregnant women at risk of premature birth to stimulate surfactant production in the neonatal lungs. NSAIDs such as ibuprofen and indomethacin can be used to close a persistent or symptomatic patent ductus arteriosus in babies.

Cyanosis, a bluish discoloration of the skin, is a common occurrence in newborns. Peripheral cyanosis, which affects the hands and feet, is often seen in the first 24 hours of life and can be caused by crying or illness. Central cyanosis, on the other hand, is a more serious condition that occurs when the concentration of reduced hemoglobin in the blood exceeds 5g/dl. To differentiate between cardiac and non-cardiac causes of central cyanosis, doctors may use the nitrogen washout test, which involves giving the infant 100% oxygen for ten minutes and then measuring arterial blood gases. A pO2 of less than 15 kPa indicates cyanotic congenital heart disease, which can be caused by conditions such as tetralogy of Fallot, transposition of the great arteries, and tricuspid atresia.

If cyanotic congenital heart disease is suspected, initial management involves supportive care and the use of prostaglandin E1, such as alprostadil, to maintain a patent ductus arteriosus in ductal-dependent congenital heart defects. This can serve as a temporary measure until a definitive diagnosis is made and surgical correction is performed.

Acrocyanosis, a type of peripheral cyanosis, is a benign condition that is often seen in healthy newborns. It is characterized by bluish discoloration around the mouth and extremities, such as the hands and feet, and is caused by vasomotor changes that result in peripheral vasoconstriction and increased tissue oxygen extraction. Unlike other causes of peripheral cyanosis that may indicate significant pathology, such as septic shock, acrocyanosis occurs immediately after birth in healthy infants and typically resolves within 24 to 48 hours.

Dilated cardiomyopathy is the most common heart condition linked to Duchenne muscular dystrophy, while acute myocardial infarctions, atrioventricular septal defects, and coronary aneurysms are not associated with this condition. Atrioventricular septal defects are, however, associated with Down syndrome, while coronary aneurysms are a complication of Kawasaki disease. Dilated cardiomyopathy is a rapidly progressive complication that typically starts in adolescence for individuals with Duchenne muscular dystrophy, an X-linked recessive condition characterized by progressive muscle wasting and weakness.

Understanding Duchenne Muscular Dystrophy

Duchenne muscular dystrophy is a genetic disorder that is inherited in an X-linked recessive manner. It affects the dystrophin genes that are essential for normal muscular function. The disorder is characterized by progressive proximal muscle weakness that typically begins around the age of 5 years. Other features include calf pseudohypertrophy and Gower’s sign, which is when a child uses their arms to stand up from a squatted position. Approximately 30% of patients with Duchenne muscular dystrophy also have intellectual impairment.

To diagnose Duchenne muscular dystrophy, doctors typically look for elevated levels of creatinine kinase in the blood. However, genetic testing has now replaced muscle biopsy as the preferred method for obtaining a definitive diagnosis. Unfortunately, there is currently no effective treatment for Duchenne muscular dystrophy, so management is largely supportive.

The prognosis for Duchenne muscular dystrophy is poor. Most children with the disorder are unable to walk by the age of 12 years, and patients typically survive to around the age of 25-30 years. Duchenne muscular dystrophy is also associated with dilated cardiomyopathy, which can further complicate the management of the disorder.

The most probable diagnosis for an infant under eight weeks who is experiencing milky vomits after feeds, particularly when laid flat, and excessive crying during feeds is gastro-oesophageal reflux. This is supported by the risk factor of preterm delivery in this case. Coeliac disease is an unlikely diagnosis as the child is exclusively breastfed and would typically present with diarrhoea and failure to thrive when introduced to cereals. Cow’s milk protein intolerance/allergy is also unlikely as it is more commonly seen in formula-fed infants and would typically present with additional symptoms such as atopy and diarrhoea. Duodenal atresia, which causes bilious vomiting in neonates a few hours after birth, is also an unlikely diagnosis for a six-week-old infant experiencing white vomitus.

Understanding Gastro-Oesophageal Reflux in Children

Gastro-oesophageal reflux is a common cause of vomiting in infants, with around 40% of babies experiencing some degree of regurgitation. However, certain risk factors such as preterm delivery and neurological disorders can increase the likelihood of developing this condition. Symptoms typically appear before 8 weeks of age and include vomiting or regurgitation, milky vomits after feeds, and excessive crying during feeding. Diagnosis is usually made based on clinical observation.

Management of gastro-oesophageal reflux in children involves advising parents on proper feeding positions, ensuring the infant is not being overfed, and considering a trial of thickened formula or alginate therapy. Proton pump inhibitors are not recommended unless the child is experiencing unexplained feeding difficulties, distressed behavior, or faltering growth. Ranitidine, previously used as an alternative to PPIs, has been withdrawn from the market due to the discovery of carcinogens in some products. Prokinetic agents should only be used with specialist advice.

Complications of gastro-oesophageal reflux in children include distress, failure to thrive, aspiration, frequent otitis media, and dental erosion in older children. In severe cases where medical treatment is ineffective, fundoplication may be considered. It is important for parents and caregivers to understand the symptoms and management options for gastro-oesophageal reflux in children to ensure the best possible outcomes for their little ones.

The Apgar score is a tool used to evaluate the health of a newborn baby. It is recommended by NICE to be assessed at 1 and 5 minutes after birth, and again at 10 minutes if the initial score is low. The score is based on five factors: pulse, respiratory effort, color, muscle tone, and reflex irritability. A score of 0-3 is considered very low, 4-6 is moderate low, and 7-10 indicates that the baby is in good health. The score helps healthcare professionals quickly identify any potential issues and provide appropriate care.

The appropriate initial treatment for meningitis in patients over 3 months of age is intravenous administration of a 3rd generation cephalosporin, specifically ceftriaxone. This is important to consider in patients with non-specific symptoms but concerning observations and examination findings. Intramuscular or oral benzylpenicillin is not the correct choice for initial empirical therapy, as it is reserved for use in the community before transfer to the hospital. Intravenous cephalexin is also not appropriate, as it is a first-generation cephalosporin and is administered orally rather than intravenously.

Investigation and Management of Meningitis in Children

Meningitis is a serious condition that can affect children. When investigating meningitis, it is important to note any contraindications to lumbar puncture, such as signs of raised intracranial pressure, focal neurological signs, papilloedema, significant bulging of the fontanelle, disseminated intravascular coagulation, or signs of cerebral herniation. For patients with meningococcal septicaemia, a lumbar puncture is contraindicated, and blood cultures and PCR for meningococcal should be obtained instead.

The management of meningitis in children involves administering antibiotics, such as IV amoxicillin (or ampicillin) and IV cefotaxime for children under three months, and IV cefotaxime (or ceftriaxone) for children over three months. Steroids should be considered if the lumbar puncture reveals certain findings, such as purulent cerebrospinal fluid, a high white blood cell count, or bacteria on Gram stain. Fluids should be administered to treat shock, and cerebral monitoring should be conducted, including mechanical ventilation if necessary.

It is also important to notify public health authorities and administer antibiotic prophylaxis to contacts. Ciprofloxacin is now preferred over rifampicin for this purpose. Overall, prompt and appropriate management of meningitis in children is crucial for ensuring the best possible outcomes.

Assessing Acute Asthma Attacks in Children

When assessing the severity of asthma attacks in children, the 2016 BTS/SIGN guidelines recommend using specific criteria. These criteria can help determine whether the attack is severe or life-threatening. For a severe attack, the child may have a SpO2 level below 92%, a PEF level between 33-50% of their best or predicted, and may be too breathless to talk or feed. Additionally, their heart rate may be over 125 (for children over 5 years old) or over 140 (for children between 1-5 years old), and their respiratory rate may be over 30 breaths per minute (for children over 5 years old) or over 40 (for children between 1-5 years old). They may also be using accessory neck muscles to breathe.

For a life-threatening attack, the child may have a SpO2 level below 92%, a PEF level below 33% of their best or predicted, and may have a silent chest, poor respiratory effort, agitation, altered consciousness, or cyanosis. It is important for healthcare professionals to be aware of these criteria and to take appropriate action to manage the child’s asthma attack. By following these guidelines, healthcare professionals can help ensure that children with asthma receive the appropriate care and treatment they need during an acute attack.